Drugs / acolbifene
acolbifene
also known as
acolbifene hydrochloride · Acolbifene hcl · Acolbifeno · Em-652 · SCH-57068 · SCH-57068 HYDROCHLORIDE · SCH57068 HCL
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT05941520 | Oct 2024 → Aug 2027 expected | ductal breast carcinoma in situ, lobular breast carcinoma in situ | National Cancer Institute (NCI) | Recruiting | No outcome recorded |
| Phase 2 | NCT00853996 | Feb 2009 → Dec 2010 | breast cancer | University of Kansas Medical Center | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01452373 | Oct 2011 → Dec 2012 | — | EndoCeutics Inc. | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acolbifene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01452373 ↗ |
| Known as | Acolbifene hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL68055 ↗ |
| Known as | acolbifene hydrochloride | “Patients receive oral acolbifene hydrochloride once daily for 6 months in the absence of unacceptable toxicity.” NCT00853996 ↗1“Drug: Acolbifene Hydrochloride” NCT05941520 ↗ |
| Known as | Acolbifeno | ChEMBL registry synonym — accepted as the source's own label CHEMBL68055 ↗ |
| Known as | Em-652 | ChEMBL registry synonym — accepted as the source's own label CHEMBL68055 ↗ |
| Known as | SCH-57068 | ChEMBL registry synonym — accepted as the source's own label CHEMBL68055 ↗ |
| Known as | SCH-57068 HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL68055 ↗ |
| Known as | SCH57068 HCL | ChEMBL registry synonym — accepted as the source's own label CHEMBL68055 ↗ |
| Action | Inhibit | “Acolbifene and tamoxifen blocks the use of estrogen by breast cells.” NCT05941520 ↗ |
| Modality | Other / unclassified | “acolbifene (a selective estrogen receptor modulator (SERM))” NCT01452373 ↗ |
| Route | Oral | “Given orally” NCT00853996 ↗ |